fbpx

Tag: FDA

FDA Approves Ketamine for Treatment-Resistant Depression

FDA Approves Ketamine for Treatment-Resistant Depression ketamine nasal spray

Yesterday, on March 5, 2019, the FDA approved the use of ketamine for treatment-resistant depression. The new drug Spravato is a nasal spray that will only be available at specialty pharmacies, clinics, and doctor’s offices. Patients are not allowed to take it home with them. Although access to Spravato is highly restricted and it can […]

Call Now Button